Myrio Showcases Innovative KRAS Immunotherapy Research at SITC Spring Edition, San Diego March 12-14th 2025March 14, 2025Myrio Tx publishes in Cancer CellJune 6, 2025 April 15, 2025 Related postsJune 17, 2025U.S. Food & Drug Administration (FDA) Approves Investigational New Drug (IND) Application for Myrio’s Lead Product (PHOX2B PC-CAR T) for the Treatment of NeuroblastomaRead moreJune 6, 2025Myrio Tx publishes in Cancer CellRead moreMarch 14, 2025Myrio Showcases Innovative KRAS Immunotherapy Research at SITC Spring Edition, San Diego March 12-14th 2025Read more